Domestic Nitrile Glove Procurement

Summary#

This bill requires Federal purchases of nitrile (non-surgical) exam gloves to follow the domestic-sourcing and long-term contracting rules in the Make PPE in America Act. It forces shared procurement vehicles (including AbilityOne-related arrangements) to use written supplier agreements with U.S. glove makers and to buy gloves that are made only by qualified domestic manufacturers. The broad goal is to make sure the Federal Government buys nitrile gloves that are made in the United States from companies it can rely on long term.

• Main change: Covered procurement vehicles must include supplier agreements of at least two years with binding purchase commitments and must source gloves exclusively from qualified domestic manufacturers.
• Defines “qualified domestic manufacturer”: must make gloves in the U.S., be majority owned and controlled by U.S. persons, not be owned/controlled by a foreign entity of concern, and have commercial-scale capacity.
• Manufacturer duties: “Manufacture” is defined to require principal production activities (forming, dipping, curing, testing, packaging), not just resale or warehousing.
• Documentation and enforcement: Agencies must certify in the contract file that procurement vehicles comply and must take corrective action if they do not.
• Preserves AbilityOne use: The bill says it does not prohibit using the AbilityOne Program and does not automatically remove items from AbilityOne lists if they are supplied by a qualified domestic manufacturer.
• Implementation: Agency heads must bring existing procurement vehicles into compliance where possible, using modifications rather than immediate re-competition.

What it means for you#

• Covered agencies (DHS, HHS, VA, DOD and others using shared vehicles):

  • Must ensure contracts and ordering arrangements for nitrile gloves comply with this law.
  • Must keep a written certification in the contract file that glove purchases meet the bill’s rules.
  • Must generally keep buying from the named U.S. manufacturer for the term of the supplier agreement unless certain exceptions apply.

• AbilityOne-participating nonprofit agencies, central nonprofit agencies, authorized distributors, prime vendors, and contractors:

  • Must use supplier agreements that meet the bill’s requirements if they furnish nitrile gloves to the Federal Government through covered procurement vehicles.
  • Supplier agreements must be enforceable directly with the qualified domestic manufacturer and last at least two years.

• U.S. glove manufacturers:

  • To be eligible under this law, a manufacturer must perform the main production steps in the U.S., be majority U.S.-owned and controlled, not be subject to significant foreign influence, and show capacity to produce at commercial scale.
  • May be asked to enter supplier agreements with minimum purchase commitments and agreed pricing, delivery, and quality terms.

• Foreign glove manufacturers and non-U.S. suppliers:

  • Gloves manufactured outside the U.S. would not qualify under this law for covered procurement vehicles.

• General public / taxpayers:

  • The law aims to shift Federal nitrile glove purchases toward U.S.-made products and longer supplier commitments. The bill does not itself include a cost estimate.

Expenses#

No publicly available information.

• The bill text does not include a fiscal note or a government cost estimate.
• This could mean agencies may incur administrative costs to modify contracts, create and retain certifications, and monitor supplier agreements.
• This could mean procurement prices or supplier options change if buying exclusively from U.S.-based qualified manufacturers requires different pricing or sourcing, but the bill gives no cost figures.

Proponents' View#

• The bill appears intended to ensure Federal nitrile glove purchases meet domestic sourcing and long-term contracting rules already set out in the Make PPE in America Act.
• A possible argument for the bill is that it strengthens supply reliability by tying purchases to U.S. manufacturers with enforceable, multi-year commitments.
• This could be seen as supporting domestic industrial capacity and ensuring the Government can obtain gloves for medical, public health, emergency response, and related uses from known U.S. sources.
• The bill preserves existing AbilityOne arrangements while adding requirements to ensure domestic manufacturing and long-term supplier relationships.

Opponents' View#

• One concern is that the bill may reduce procurement flexibility by requiring exclusive sourcing from identified domestic manufacturers and limiting substitutions without formal modifications.
• The bill does not include a cost estimate; a possible trade-off is higher procurement or administrative costs if domestic-only sourcing is more expensive or requires contract changes.
• It is unclear how agencies will determine whether a firm is subject to “significant influence” by a foreign entity of concern; the bill allows agency heads to make this determination, which could raise consistency or legal questions.
• The requirement that manufacturers have “demonstrated capacity” at commercial scale is not detailed, so practical standards and verification methods are unclear.
• The bill relies on agencies to certify compliance and use existing procurement law for corrective action; it does not create a new enforcement mechanism beyond existing procurement remedies.